Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The Study Details page remains the same, with identical sections and values across screenshots; only minor formatting/layout differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-31T12:03:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Update: the page version is updated from v3.0.2 to v3.2.0. No other content changes detected.
    Difference
    0.0%
    Check dated 2025-10-01T02:49:35.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Updated the revision/version from v3.0.2 to v3.1.0, indicating a new release with presumably updated features or fixes, while core content remains unchanged.
    Difference
    0.0%
    Check dated 2025-09-30T02:51:31.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2. The old v3.0.1 tag was removed and the Back to Top navigation control was deleted.
    Difference
    0.1%
    Check dated 2025-09-15T19:26:42.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-08T15:04:44.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated to include new studies related to cancer immunotherapy, specifically focusing on lenvatinib and pembrolizumab, while also removing some previously listed location details and related terms.
    Difference
    3%
    Check dated 2025-09-01T09:41:17.000Z thumbnail image

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.